2024-10-12 - Analysis Report
## CVS Health Corp (CVS) Stock Analysis Report 

**1. Performance Comparison:**

CVS Health Corp (CVS) has significantly underperformed the S&P 500 (VOO) over the period analyzed. Its cumulative return of -28.81% stands in stark contrast to VOO's 134.11%. This translates to a substantial divergence of -162.92, indicating that CVS has significantly lagged behind the market benchmark. However, it's important to note that this relative divergence is within its historical range (max: 9.31, min: -163.33), suggesting its current performance isn't entirely out of line with its historical behavior.

**2. Recent Price Movement:**

CVS is currently trading at $67.05. 
- The 5-day moving average stands at $65.75, suggesting a slight upward trend in the short term.
- The 20-day moving average is at $61.07, indicating a broader upward trend over the past month.
- The 60-day moving average sits at $59.18, implying a sustained upward momentum over the last three months. 

**3. Technical Indicators:**

- **RSI (89.04):** The RSI is currently in overbought territory, suggesting the stock is approaching or may already be at its peak.
- **PPO (1.12):** The PPO index indicates a strong positive momentum, further confirming the stock's recent uptrend.
- **Delta_Previous_Relative_Divergence (-0.3):** This indicates a slight bearish divergence, signaling a potential short-term pullback.
- **Expected_Return (0.0%):** This suggests that, based on historical data, CVS is not expected to outperform the S&P 500 (VOO) in the next five years.

**4. Recent Earnings and Outlook:**

| Date | EPS | Estimated EPS |
|---|---|---|
| 2024-08-07 | 1.83 | 1.73 |
| 2024-05-01 | 1.31 | 1.7 |
| 2024-02-07 | 2.12 | 2.01 |
| 2023-11-01 | 2.21 | 2.13 |
| 2023-08-02 | 2.21 | 2.12 |

The latest earnings report for the quarter ending August 7th, 2024, showed an EPS of 1.83, exceeding the estimated EPS of 1.73. This positive result suggests that CVS is performing well and exceeding expectations. However, it's important to note that the overall earnings trend has shown some fluctuations.

**5. News and Recent Issues:**

CVS has been in the news recently for its focus on expanding its healthcare services and pharmacy footprint. Analysts are generally optimistic about CVS's long-term prospects, citing its strong market position, diversified business model, and commitment to growth through acquisitions and strategic partnerships.

**6. Overall Analysis:**

CVS is a large, well-established company with a strong presence in the healthcare sector. While its recent performance has lagged behind the market, the company's strong financial position and growth potential warrant a closer look. The stock is currently showing signs of positive momentum, but its overbought RSI suggests caution and potential short-term pullback. Investors should carefully consider the company's long-term prospects and the overall market conditions before making any investment decisions.

**7. Disclaimer:**
This analysis is for informational purposes only and should not be considered financial advice.  Always consult with a qualified financial advisor before making any investment decisions. 
